The CRC series "Current Topics in Nonclinical Drug Development Series" explores the critical issues and current topics important in nonclinical drug development. Individual volumes within this series will cover 10-12 individual topics and strategies in drug development from compound characterization to drug registration. The series is designed to be an up-to-date tool and current resource for toxicologists, toxicologic pathologists, consultants, regulators, Study Directors, and nonclinical scientists dealing with day-to-day issues in study design, evaluation of findings, and presentation of data. In addition, the series will serve as an aid to academicians and graduate students pursuing research on nonclinical drug development. Each book within the series will be authored by experts in the field focused on both the art and science of nonclinical drug development and its impact on translational medicine and human safety.
Edited
By Pritam S. Sahota, Philip Bentley, Zbigniew Wojcinski
October 18, 2023
The second volume in the CURRENT TOPICS IN NONCLINICAL DRUG DEVELOPMENT SERIES explores the critical issues and current topics in nonclinical drug development. This second volume covers individual topics and strategies in drug development from compound characterization to drug registration. Written...
Edited
By Pritam S. Sahota, Philip Bentley, Zbigniew Wojcinski
December 23, 2020
The inaugural volume in the Current Topics in Nonclinical Drug Development Series explores the critical issues and current topics in nonclinical drug development. This first volume covers individual topics and strategies in drug development from compound characterization to drug registration. ...